Abstract
Plant-derived alpha-linolenic acid has been studied in a limited number of investigations. So far, some epidemiologic and a few mechanistic studies suggest a potential of protection from cardiovascular disease, but this potential remains to be proven in intervention studies. In contrast, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), which are prevalent in fish and fish oils, have been studied in thousands of investigations. A consistent body of evidence has been elaborated in various types of investigations, ultimately demonstrating reduction in total mortality, cardiovascular mortality, and morbidity by ingestion of roughly I g/d of EPA plus DHA. Current guidelines, however, do not discern between the omega-3 fatty acids mentioned; in fact, most even do not differentiate polyunsaturated fatty acids at all. Unfortunately, this complicates efficient implementation of an effective means of prophylaxis of atherosclerosis.
Similar content being viewed by others
References and Recommended Reading
von Schacky C: Prophylaxis of atherosclerosis with marine omega-3 fatty acids. A comprehensive strategy. Ann Intern Med 1987, 107: 890–899.
Djousse L, Pankow JS, Folsom AR, et al.: Relation between dietary linolenic acid and coronary artery disease in the national heart, lung, and blood institute family heart study. Am J Clin Nutr 2001, 74: 612–619.
Oomen CM, Ocke MC, Feskens EJ, et al.: alpha-Linolenic acid intake is not beneficially associated with 10-y risk of coronary artery disease incidence: the Zutphen Elderly Study. Am J Clin Nutr 2001, 74: 457–463.
Ascherio A, Rimm EB, Giovannucci EL, et al.: Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ 1996, 313: 84–90.
Hu FB, Stampfer MJ, Manson JE, et al.: Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr 1999, 69: 890–897.
McLennan PL, Dallimore JA: Dietary canola oil modifies myocardial fatty acids and inhibits cardiac arrhythmias in rats. J Nutr 1995, 125: 1003–1009.
Billman GE, Kang JX, Leaf A: Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation 1999, 99: 2452–2457.
Christensen JH, Christensen MS, Toft E, et al.: Alpha-linoleic acid and heart rate variability. Nutr Metab Cardiovasc Dis 2000, 10: 57–61.
Renaud S, Nordoy A: “Small is beautiful”: Alpha-linolenic acid and eicosapentaenoic acid in man. Lancet 1983, 1: 1169.
Owren PA, Hellem AJ, Odegnard A: Linolenic acid for the prevention of thrombosis myocardial infarction. Lancet 1964, 2: 975–979.
Wensing AG, Mensink RP, Hornstra G: Effects of dietary n-3 polyunsaturated fatty acids from plant and marine origin on platelet aggregation in healthy elderly subjects. Br J Nutr 1999, 82: 183–191.
Thies F, Miles EA, Nebe-von-Caron G, et al.: Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 2001, 36: 1193–1193.
Nestel PJ, Pomeroy SE, Sasahara T, et al.: Arterial compliance in obese subjects is improved with dietary plant n-3 fatty acid from flaxseed oil despite increased LDL oxidizability. Arterioscler Thromb Vasc Biol 1997, 17: 1163–1170.
Singh RB, Niaz MA, Sharma NJ, et al.: Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the indian experiments of infarct survival. Cardiovasc Drugs Ther 1997, 11: 485–491.
de Lorgeril M, Renaud S, Mamelle N, et al.: Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994, 343: 1454–1459.
de Lorgeril M, Salen P, Martin JL, et al.: Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction. Final report of the Lyon diet heart study. Circulation 1999, 99: 779–785.
Kromann N, Green A: Epidemiological studies in Upernavik District, Greenland. Acta Med Scand 1980, 208: 401–406.
Kromhout D, Bosschieter EB, Coulander CD: The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985, 312: 1205–1209.
Daviglus ML, Stamler J, Orencia AJ, et al.: Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med 1997, 336: 1046–1053.
Siscovick DS, Raghunathan TE, King I, et al.: Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995, 274: 1363–1367.
Dolecek TA, Grandits G: Dietary polyunsaturated fatty acids and mortality in the multiple Risk Factor Intervention Trial (MRFIT). World Rev Nutr Diet 1991, 66: 205–216.
Hu FB, Bronner L, Willett WC, et al.: Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002, 287: 1815–1821.
Albert CM, Campos H, Stampfer MJ, et al.: Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002, 346: 1113–1118.
Iso H, Rexrode KM, Stampfer MJ, et al.: Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA 2001, 285: 304–312.
Dyerberg J, Bang HO, Stoffersen E, et al.: Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978, 2: 117–119.
Harris WS: n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 1997, 65(suppl 5): 1645S-1654S.
von Schacky C, Angerer P, Kothny W, et al.: The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999, 130: 554–562.
Endres S, Ghorbani R, Kelley VE, et al.: The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989, 320: 265–271.
Kaminski WE, Jendraschak E, Kiefl R, von Schacky C: Dietary omega-3 fatty acids lower levels of platelet-derived growth factor mRNA in human mononuclear cells. Blood 1993, 81: 1871–1879.
Baumann KH, Hessel F, Larass I, et al.: Dietary omega-3, omega-6, and omega-9 unsaturated fatty acids and growth factor and cytokine gene expression in unstimulated and stimulated monocytes. A randomized volunteer study. Arterioscler Thromb Vasc Biol 1999, 19: 59–66.
De Caterina R, Zampolli A: n-3 fatty acids: antiatherosclerotic effects. Lipids 2001, 36(suppl): S69-S78.
Kang JX, Xiao YF, Leaf A: Free, long-chain, polyunsaturated fatty acids reduce membrane electrical excitability in neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A 1995, 92: 3997–4001.
McLennan PL: Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models. Lipids 2001, 36(suppl): S111-S114.
Sellmayer A, Witzgall H, Lorenz RL, Weber PC: Effects of dietary fish oil on ventricular premature complexes. Am J Cardiol 1995, 76: 974–977.
Furberg CD, Psaty BM, Pahor M, Alderman MH: Clinical implications of recent findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALL-HAT) and other studies of hypertension. Ann Intern Med 2001, 135: 1074–1078.
D’Agostino RB Jr: Debate: The slippery slope of surrogate out-comes. Curr Control Trials Cardiovasc Med 2000, 1: 76–78.
Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico: Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999, 354: 447–455.
Yusuf S, Dagenais G, Pogue J, et al.: Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342: 154–160.
Lorenz R, Spengler U, Fischer S, et al.: Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with cod liver oil. Circulation 1983, 67: 504–511.
Singer P, Jaeger W, Wirth M, et al.: Lipid and blood pressure-lowering effect of mackerel diet in man. Atherosclerosis 1983, 49: 99–108.
Morris MC, Sacks F, Rosner B: Does fish oil lower blood pressure? A meta-analysis of controlled trials. Circulation 1993, 88: 523–533.
Mori TA, Bao DQ, Burke V, et al.: Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 1999, 34: 253–260.
Fleischhauer FJ, Yan WD, Fischell TA: Fish oil improves endothelium-dependent coronary vasodilation in heart transplant recipients. J Am Coll Cardiol 1993, 21: 982–989.
Goodfellow J, Bellamy MF, Ramsey MW, et al.: Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol 2000, 35: 265–270.
Kothny W, Angerer P, Stork S, von Schacky C: Short term effects of omega-3 fatty acids on the radial artery of patients with coronary artery disease. Atherosclerosis 1998, 140: 181–186.
Chin JP, Gust AP, Nestel PJ, Dart AM: Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension 1993, 21: 22–28.
Chin JP, Gust AP, Dart AM: Indomethacin inhibits the effects of dietary supplementation with marine oils on vasoconstriction of human forearm resistance vessels in vivo. J Hypertens 1993, 11: 1229–1234.
Leeson CP, Hingorani AD, Mullen MJ, et al.: Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ Res 2002, 90: 1153–1158.
McVeigh GE, Brennan GM, Johnston GD, et al.: Dietary fish oil augments nitric oxide production or release in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993, 36: 33–38.
Mori TA, Watts GF, Burke V, et al.: Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 2000, 102: 1264–1269.
Nestel P, Shige H, Pomeroy S, et al.: The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans. Am J Clin Nutr 2002, 76: 326–330.
Christensen JH, Skou HA, Madsen T, et al.: Heart rate variability and n-3 polyunsaturated fatty acids in patients with diabetes mellitus. J Intern Med 2001, 249: 545–552.
Christensen JH, Skou HA, Fog L, et al.: Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation 2001, 103: 651–657.
Villa B, Calabresi L, Chiesa G, et al.: Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease. Pharmacol Res 2002, 45: 475.
Christensen JH, Gustenhoff P, Korup E, et al.: Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ 1996, 312: 677–678.
Gapinski JP, VanRuiswyk JV, Heudebert GR, Schectman GS: Preventing restenosis with fish oils following coronary angioplasty. A metanalysis. Arch Intern Med 1993, 153: 1595–1601.
Leaf A, Jorgensen MB, Jacobs AK, et al.: Do fish oils prevent restenosis after coronary angioplasty? Circulation 1994, 90: 2248–2257.
Cairns JA, Gill J, Morton B, et al.: Fish oils and low-molecular-weight heparin for the reduction of restenosis after percutaneous transluminal coronary angioplasty—the EMPAR study. Circulation 1996, 94: 1553–1560.
Eritsland J, Arnesen H, Gronseth K, et al.: Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. Am J Cardiol 1996, 77: 31–36.
Sacks FM, Stone PH, Gibson CM, et al.: Controlled trial of fish oil for regression of human coronary atherosclerosis. J Am Coll Cardiol 1995, 25: 1492–1498.
Angerer P, Kothny W, Stork S, von Schacky C: Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries. Cardiovasc Res 2002, 54: 183–190.
Burr ML, Fehily AM, Gilbert JF, et al.: Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989, 2: 757–761.
Ness AR, Hughes J, Elwood PC, et al.: The long-term effect of dietary advice in men with coronary disease: follow-up of the Diet and Reinfarction trial (DART). Eur J Clin Nutr 2002, 56: 512–518.
Marchioli R, Barzi F, Bomba E, et al.: Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002, 105: 1897–1903.
Pepe S, McLennan PL: Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function. Circulation 2002, 105: 2303–2308.
Smith SC Jr, Blair SN, Bonow RO, et al.: AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 update. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. J Am Coll Cardiol 2001, 38: 1581–1583.
Krauss RM, Eckel RH, Howard B, et al.: AHA Dietary Guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 2000, 102: 2284–2299.
Hooper L, Summerbell CD, Higgins JP, et al.: Dietary fat intake and prevention of cardiovascular disease: systematic review. BMJ 2001, 322: 757–763.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
von Schacky, C. The role of omega-3 fatty acids in cardiovascular disease. Curr Atheroscler Rep 5, 139–145 (2003). https://doi.org/10.1007/s11883-003-0086-y
Issue Date:
DOI: https://doi.org/10.1007/s11883-003-0086-y